Canadian Journal of Physiology and Pharmacology

The endocrine heart: 30 years later (23rd Meeting for the International Society of Hypertension)
pp. v-vi(2)

Thirty years of research on atrial natriuretic factor: historical background and emerging concepts
pp. 527-531(5)
Author: de Bold, Adolfo J.

Atrial natriuretic factor in the developing heart: a signpost for cardiac morphogenesis
pp. 533-537(5)
Author: Bruneau, Benoit G.

M-CAT element mediates mechanical stretch-activated transcription of B-type natriuretic peptide via ERK activation
pp. 539-550(12)
Authors: Koivisto, Elina; Karkkola, Laura; Majalahti, Theresa; Aro, Jani; Tokola, Heikki; Kerkelä, Risto; Ruskoaho, Heikki

Roles of guanylyl cyclase-A signaling in the cardiovascular system
pp. 551-556(6)
Authors: Saito, Yoshihiko; Kishimoto, Ichiro; Nakao, Kazuwa

Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation
pp. 557-573(17)
Author: Pandey, Kailash N.

Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives
pp. 575-585(11)
Authors: Fonteles, Manassés Claudino; do Nascimento, Nilberto Robson Falcão

Atrial natriuretic peptides in heart failure: pathophysiological significance, diagnostic and prognostic value
pp. 587-591(5)
Authors: Ghosh, Nina; Haddad, Haissam

Designer natriuretic peptides: a vision for the future of heart failure therapeutics
pp. 593-601(9)
Authors: Zakeri, Rosita; Burnett, John C.

Tailored therapy for heart failure: neurohormones
pp. 603-607(5)
Author: Richards, A. Mark

Recent success in the discovery of coronary artery disease genes
pp. 609-615(7)
Authors: Roberts, Robert; Chen, Li; Wells, George A.; Stewart, Alexandre F.R.